SANOFI CONS HEALTHC IND L Share Price

SANOFI CONS HEALTHC IND L Share Price

NSE: SANOFICONR
|
Pharmaceuticals
₹ 4,542.30
-₹24.90 (-0.55%)
1D
Last updated 20 Jul, 2026, 11:07 IST

SANOFI CONS HEALTHC IND L Share Price Today

As of 20 Jul 2026, SANOFI CONS HEALTHC IND L share price is ₹4,542.30. The stock opened at ₹4,658.00, compared to its previous close of ₹4,567.20. During today's trading session, SANOFI CONS HEALTHC IND L share price moved in the range of ₹4,524.30 to ₹4,658.00, with an average price of ₹4,591.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,975.00 and a high of ₹5,512.00. On the performance front, SANOFI CONS HEALTHC IND L share price has increased by 10.82% over the last six months and is down 10.93% on a year-on-year basis.

₹4,524.30
0.55% down today
₹4,658.00
1D LOW
1D HIGH

SANOFI CONS HEALTHC IND L Returns Calculator

Open
₹4,658.00
High
₹4,658.00
Low
₹4,524.30
Prev. close
₹4,567.20
Circuit
L
H
₹3,653.80
₹5,480.60
52-week
L
H
₹3,975.00
₹5,512.00

SANOFI CONS HEALTHC IND L Shareholder Returns

SANOFI CONS HEALTHC IND L Share Price History

Mkt Cap Cr
10,539.00
P/E
42.27
P/B
35.83
ROE
77.82%
D/E
0.11
ROCE
92.58%
Div. Yield
1.37%
EPS(TTM)
0.00
Turnover
1.89
EV/EBITDA
30.28
Net Margin
27.33%
Op. Margin
38.02%
ROA
51.64%
Quick Ratio
3.37
Curr. Ratio
2.91
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Sanofi Consumer has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Sanofi Consumer appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,815.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,92,678.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,61,323.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,14,585.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Zydus Lifesciences1,13,990.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,11,661.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,02,896.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories1,01,067.0024.972.7511.64%0.1513.65%3.320.64%0.6338.68
Aurobindo Pharma89,097.9025.442.359.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,639.3060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

SANOFI CONS HEALTHC IND L Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023
Revenue₹878.40₹724.50₹555.40
Other Income₹18.40₹13.00₹4.10
Total Revenue₹896.80₹737.50₹559.50
Total Expenses₹583.10₹462.30₹338.40
Profit Before Tax₹320.30₹246.80₹219.30
Tax₹80.20₹65.80₹54.40
Profit After Tax₹240.10₹181.00₹164.90
EPS - Basic₹104.27₹78.59₹71.60
EPS - Diluted₹104.27₹78.59₹71.60

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023
Profit before tax₹320.30₹246.80₹219.30
Income before WC changes₹316.00₹247.30₹217.10
Change in Assets-₹52.40₹266.00-₹209.90
Change in Liabilities-₹1.40₹50.10-₹3.40
Change in WC-₹53.80₹316.10-₹213.30
Cash flow from Operations₹174.80₹439.00-₹0.40
Cash flow from Investing₹7.60₹1.90₹0.00
Cash flow from Financing-₹134.50-₹115.60₹2.00
Total Cash Flow₹47.90₹325.30₹1.60
Cash (Start of the year)₹326.90₹1.60₹0.00
Cash (End of the year)₹374.80₹326.90₹1.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023
Non-Current Assets₹52.70₹39.60₹10.20
Current Assets₹494.30₹391.70₹335.20
Total Assets₹547.00₹431.30₹345.40
Current Liabilities₹128.40₹130.60₹129.90
Net Current Asset₹365.90₹261.10₹205.30
Non-Current Liabilities₹34.60₹27.70₹7.90
Equity Capital₹384.00₹273.00₹207.60
Total Equity & Liabilities₹547.00₹431.30₹345.40
* All values are in INR Crore
Qty
Bid
1
4541.3
2
4539.5
1
4539.2
1
4535.1
1
4535
Ask
Qty
4546.7
1
4547.8
1
4547.9
2
4549.3
1
4549.4
1
Bid Total: 6
Ask Total: 6
Buy orders: 50%
Sell orders: 50%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45.43
Neutral
ATR (14)
85.88
Neutral
STOCH(9,6)
45.39
Neutral
STOCH RSI (14)
91
Bearish
ADX(9)
8.25
Bullish
UO(9)
43.86
Neutral
ROC(12)
-0.88
Bearish
WillR(14)
-70.36
Neutral
Period
Simple value
Exponential vaue
5D
4559.22
4558.78
10D
4561.33
4570.38
20D
4611.72
4601.14
50D
4675.06
4623.04
100D
4551.37
4590.68

About SANOFI CONS HEALTHC IND L

SANOFI CONS HEALTHC IND L Share Price
ISIN
INE0UOS01011
Sector Market Cap
₹ 10,539 Cr

Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.

SANOFI CONS HEALTHC IND L Financial Highlights

  • Revenue: SANOFI CONS HEALTHC IND L reported revenue of ₹896.80 crore in FY25 vs ₹896.80 crore in FY25. It showed an increase of 0.00% on a yearly basis.
  • Operating Profit: SANOFI CONS HEALTHC IND L reported an operating profit of ₹320.30 crore in FY25 vs ₹320.30 crore in FY25. It showed an increase of 0.00% on a year-on-year basis.
  • Net Profit: SANOFI CONS HEALTHC IND L reported a net profit of ₹240.10 crore in FY25 vs ₹240.10 crore in FY25. It showed an increase of 0.00% on a yearly basis.

SANOFI CONS HEALTHC IND L Quarterly Result Highlights

  • SANOFI CONS HEALTHC IND L reported revenue of ₹234.80 crore in Mar 2026, compared with ₹255.60 crore in Dec 2025, representing a decrease of 8.14% on a quarter-on-quarter (QoQ) basis.
  • SANOFI CONS HEALTHC IND L reported an operating profit of ₹90.70 crore in Mar 2026, compared with ₹90.50 crore in Dec 2025, representing an increase of 0.22% on a quarter-on-quarter (QoQ) basis.
  • SANOFI CONS HEALTHC IND L reported a profit of ₹67.80 crore in Mar 2026, compared with ₹66.50 crore in Dec 2025, reflecting an increase of 1.95% on a QoQ basis.
  • The earnings per share (EPS) of SANOFI CONS HEALTHC IND L stood at ₹104.27 during Mar 2026.
Know more
Promoters
71.27%
FII
2.76%
Other DII
3.94%
Retail and other
8.40%
Mutual funds
13.63%
Foreign institutions - FII
Compare against other stocks
SANOFI CONS HEALTHC IND L Share Price
SANOFI CONS HEALTHC IND L
Pharmaceuticals
Add Stock
Add Another

FAQs on SANOFI CONS HEALTHC IND L Share Price